Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-18 Purchase | 2024-06-20 8:21 pm | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 100,000 | $0.5911 | $59,110 | 480,010 (Indirect) | View |
| 2024-03-27 Sale | 2024-03-28 6:05 pm | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 6,430 | $1.1556 | $7,431 | 472,747 (Indirect Direct) | View |
| 2023-11-13 Purchase | 2023-11-14 6:24 pm | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 200,000 | $0.5644 | $112,880 | 479,177 (Indirect Direct) | View |
| 2023-04-04 Purchase | 2023-04-05 4:26 pm | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 55,000 | $1.0199 | $56,095 | 225,157 (Indirect Direct) | View |
| 2023-03-20 Purchase | 2023-03-22 5:17 pm | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 50,000 | $0.9687 | $48,435 | 381,657 (Indirect Direct) | View |
| 2022-07-15 Purchase | 2022-07-15 4:23 pm | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 13,869 | $7.21 | $99,995 | 120,157 (Indirect Direct) | View |
| 2022-03-23 Sale | 2022-03-24 4:53 pm | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 10,722 | $8.915 | $95,587 | 106,288 (Indirect Direct) | View |
| 2021-03-23 Sale | 2021-03-25 4:11 pm | Gossamer Bio Inc. | GOSS | Giraudo Bryan Chief Financial Officer | 5,490 | $9.4801 | $52,046 | 117,010 (Indirect Direct) | View |
| 2020-10-14 Purchase | 2020-10-14 7:27 pm | Gossamer Bio Inc. | GOSS | Giraudo Bryan Chief Financial Officer | 3,000 | $10.01 | $30,036 | 77,500 (Indirect Direct) | View |
| 2020-06-23 Purchase | 2020-06-23 5:01 pm | Gossamer Bio Inc. | GOSS | Giraudo Bryan Chief Financial Officer | 2,000 | $12.96 | $25,922 | 74,500 (Indirect Direct) | View |
| 2019-12-03 Purchase | 2019-12-03 6:46 pm | Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director | 8,000 | $5.7025 | $45,620 | 18,000 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-02 Option Award | 2024-01-04 8:10 pm | N/A 2034-01-02 | Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director | 25,700 | $0 | 25,700 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 5:02 pm | N/A 2034-01-01 | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 543,750 | $0 | 543,750 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:07 pm | N/A 2033-11-19 | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 181,250 | $0 | 181,250 (Direct) | View |
| 2023-07-24 Option Award | 2023-07-26 4:03 pm | 2023-07-24 2028-07-24 | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 13,505 | $0.125 | 263,894 (Indirect) | View |
| 2023-07-24 Option Award | 2023-07-26 4:03 pm | N/A N/A | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 54,020 | $1.82 | 263,894 (Indirect) | View |
| 2023-05-05 Option Award | 2023-05-09 4:15 pm | N/A 2029-03-25 | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 481,001 | $0 | 481,001 (Direct) | View |
| 2023-05-05 Disposition | 2023-05-09 4:15 pm | N/A 2029-03-25 | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 721,500 | $0 | 481,001 (Direct) | View |
| 2023-03-20 Option Award | 2023-03-22 5:17 pm | N/A 2033-03-19 | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 211,500 | $0 | 381,657 (Direct) | View |
| 2023-01-16 Option Award | 2023-01-18 8:13 pm | N/A 2033-01-15 | Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-12-07 Option Award | 2022-12-09 5:15 pm | N/A 2032-12-06 | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 211,500 | $0 | 211,500 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-27 4:00 pm | N/A 2032-05-26 | Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 4:05 pm | N/A 2032-01-05 | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 265,000 | $0 | 265,000 (Direct) | View |
| 2021-09-16 Option Award | 2021-09-20 4:25 pm | N/A 2031-09-16 | Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO | 150,000 | $0 | 150,000 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 6:39 pm | N/A 2031-05-26 | Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 4:50 pm | N/A 2031-02-25 | Gossamer Bio Inc. | GOSS | Giraudo Bryan Chief Financial Officer | 135,000 | $0 | 212,500 (Direct) | View |
| 2020-05-28 Option Award | 2020-05-29 6:12 pm | N/A 2030-05-27 | Protagonist Therapeutics Inc | PTGX | Giraudo Bryan Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:20 pm | N/A 2030-02-14 | Gossamer Bio Inc. | GOSS | Giraudo Bryan Chief Financial Officer | 118,000 | $0 | 144,000 (Direct) | View |